Keiretsu Capital Founded 2007
Founders Matthew Le Merle Matthew Le Merle Nathan McDonald Randy Williams
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 25
Average round size
info
The average size of a deal this fund participated in
$4M
Portfolio companies 25
Rounds per year 1.79
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits -
Key employees -
Stages of investment
Early Stage Venture
Late Stage Venture
Areas of investment
Biotechnology
Finance
Health Care
Medical
Medical Device
SaaS
Summary

Keiretsu Capital appeared to be the VC, which was created in 2007. The main department of described VC is located in the Seattle. The venture was found in North America in United States.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Keiretsu Capital, startups are often financed by Keiretsu Forum, Portland Seed Fund, Band of Angels. The meaningful sponsors for the fund in investment in the same round are Keiretsu Forum, Band of Angels, Sand Hill Angels. In the next rounds fund is usually obtained by Puget Sound Venture Club, Keiretsu Forum Northwest, Tech Coast Angels.

The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are SaaS, Internet. Among the most popular portfolio startups of the fund, we may highlight Transform, Inc., Alpin, Perkville. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The usual things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2016. The fund is constantly included in 7-12 investment rounds annually. Considering the real fund results, this VC is 19 percentage points less often commits exit comparing to other organizations. When the investment is from Keiretsu Capital the average startup value is 5-10 millions dollars. This Keiretsu Capital works on 25 percentage points less the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2019.

The fund was created by Matthew Le Merle, Matthew Le Merle, Nathan McDonald, Randy Williams. We also calculated 12 valuable employees in our database.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
OtoSense
Artificial Intelligence
Automotive
Industrial Automation
Machine Learning
Machinery Manufacturing
Predictive Analytics
Security
Software
Series A
1M29 Jun 2015 United States, Palo Alto
Astarte Medical
Analytics
Health Care
Health Diagnostics
Medical
Predictive Analytics
Series A
5M07 Mar 2019 United States, Yardley
Beta Hatch
Agriculture
Animal Feed
Farming
Seed
2M05 Apr 2018 United States, Cashmere
iHealthHome
Health Care
SaaS
Wellness
Venture - Series Unknown
30 Nov 2015 United States, Seattle
Kineta
Biotechnology
Medical Device
Therapeutics
Series B
7M20 Jan 2015 United States, Seattle
LumiThera
Health Care
Medical
Medical Device
Series A
05 Oct 2015 United States, Poulsbo
KPI Therapeutics
Health Care
Medical
Therapeutics
Venture - Series Unknown
02 Dec 2015 United States, Seattle
HaptX
Hardware
Human Computer Interaction
Motion Capture
Robotics
Virtual Reality
Series A
12M20 Dec 2019 United States, Seattle
Toma Biosciences
Biotechnology
Genetics
Health Care
Series C
3M12 Jun 2021 United States, Foster City
Virion Therapeutics
Biotechnology
Health Care
Therapeutics
Series A
5M12 Jun 2021 United States, Newark
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Keiretsu Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: